Challenging Cases From the Clinic: The Patient With Chronic HCV Infection and Cirrhosis
Summary: In the REALIZE trial of patients with genotype 1 chronic HCV infection, those with relapse had the best virologic response to triple therapy with peginterferon-ribavirin and telaprevir.